{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:06:00Z","timestamp":1744949160169,"version":"3.40.4"},"reference-count":4,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaad.2025.01.063","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T23:57:53Z","timestamp":1738108673000},"page":"e159-e160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to Liu et\u00a0al., \u201cResponse to Ormaza Vera et\u00a0al. \u201cInterleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic-na\u00efve patients with psoriasis: A retrospective cohort study\u201d\u201d"],"prefix":"10.1016","volume":"92","author":[{"given":"Ana","family":"Ormaza Vera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-1904","authenticated-orcid":false,"given":"Clinton W.","family":"Enos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.01.063_bib1","article-title":"\u201cInterleuking 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic-na\u00efve patients with psoriasis: A retrospective cohort study\u201d","author":"Wei-Wei","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.063_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaad.2024.09.063","article-title":"Interleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared with biologic-naive patients with psoriasis: A retrospective cohort study","volume":"92","author":"Ormaza","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.01.063_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaad.2024.07.1511","article-title":"Major adverse cardiovascular events are more frequent in psoriasis patients compared to controls, despite statin therapy: An observational retrospective cohort study","volume":"91","author":"Ormaza","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.01.063_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jaad.2022.05.038","article-title":"Similar response to biologic therapy across racial and ethnic groups among patients with psoriasis enrolled in the CorEvitas Psoriasis Registry","volume":"87","author":"Enos","year":"2022","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225001483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225001483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T03:56:27Z","timestamp":1744862187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225001483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0190962225001483"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.063","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to Liu et\u00a0al., \u201cResponse to Ormaza Vera et\u00a0al. \u201cInterleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic-na\u00efve patients with psoriasis: A retrospective cohort study\u201d\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.044","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}